共 133 条
[1]
Archer S(2010)Basic science of pulmonary arterial hypertension for clinicians new concepts and experimental theories Circulation 121 2045-U175
[2]
Weir E(2013)Development of controlled release inhalable polymeric microspheres for treatment of pulmonary hypertension Int J Pharm 450 114-122
[3]
Wilkins M(2004)Cellular and molecular pathobiology of pulmonary arterial hypertension J am Coll Cardiol 43 S13-S24
[4]
Saigal A(2013)FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension J Clin Investig 123 3600-3613
[5]
Ng WK(2006)Particle engineering techniques for inhaled biopharmaceuticals Adv Drug Deliv rev 58 1009-1029
[6]
Tan RBH(2013)Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols Int J Nanomedicine 8 275-293
[7]
Chan SY(2001)Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance J Control Release 70 329-339
[8]
Humbert M(2003)Control of the morphology of nanostructured particles prepared by the spray drying of a nanopartcile sol J Colloid Interface Sci 265 296-303
[9]
Morrell NW(2014)Use of a fundamental approach to spray-drying formulation design to facilitate the development of multi-component dry powder aerosols for respiratory drug delivery Pharm res 31 449-465
[10]
Archer SL(2014)High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physiochemical characterization, in vitro aerosol dispersion, and cellular studies AAPS PharmSciTech 15 1574-1587